Asthma is a manageable condition with a bit of education and consistency. Here's what to keep in mind, and when to take ...
In a 7-2 ruling, the Supreme Court sided with the manufacturer of Roundup, overturning a Missouri jury award for a man who claimed the herbicide caused cancer. The decision is expected to block ...
Aniline can now be transformed into pyridine without adding any catalysts, oxidants or toxic reagents. In a recent study ...
Electromed benefits from a new CMS rule and a recently approved bronchiectasis drug, driving increased disease awareness.
On track to complete enrollment of MIST Phase 2b trial of AP01 in progressive pulmonary fibrosis (PPF) in mid-2026, with newly presented long ...
Baby calves rely on it to build up their immune systems and gut. And now marketers are promoting it for humans. Here's what ...
Kyle Busch died on May 21 at age 41 of pneumonia that progressed into sepsis, according to a statement shared by the NASCAR legend's family on Saturday, May 23. The statement added that the ...
The World Health Organization declared an Ebola outbreak in the Democratic Republic of the Congo and Uganda a public health emergency of international concern on May 17, but said it did not meet the ...
Make this your preferred source to get more updates from this publisher on Google. An 80-year-old father in Laguna died after failing to undergo nebulization during a rotational brownout, as several ...
Nebulizer use was highest among those with more severe COPD. Nearly half of patients in the most advanced stage reported using nebulizers, showing a clear link between disease severity and treatment ...
Redd’s daily treatment reveals how orangutans with chronic respiratory diseases are adapting to use certain medical tools designed for humans. Mike Bock Redd, left, and his mother, Batang, right. Both ...
(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...